GNE-955
CAS No. 1527523-39-2
GNE-955( GNE955 )
Catalog No. M12142 CAS No. 1527523-39-2
GNE-955 is a potent, selective pan-Pim inhibitor with Ki of 0.018/0.11/0.008 nM for Pim1/2/3, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1143 | In Stock |
|
| 50MG | 2322 | In Stock |
|
| 100MG | 3060 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGNE-955
-
NoteResearch use only, not for human use.
-
Brief DescriptionGNE-955 is a potent, selective pan-Pim inhibitor with Ki of 0.018/0.11/0.008 nM for Pim1/2/3, respectively.
-
DescriptionGNE-955 is a potent, selective pan-Pim inhibitor with Ki of 0.018/0.11/0.008 nM for Pim1/2/3, respectively; shows only 3 kinases >80% inhibition (Pim-1, 100%; CLK1, 97%; Flt3, 82%) at 0.1 uM in a panel of 70 kinases; shows excellent bioavailability in rat.
-
In VitroGNE-955 inhibits proliferation of MM.1S cells, with an IC50 value of 0.5 μM after 72 hours treatment.GNE-955 (0.156-5 μM) inhibits the phosphorylation of BAD (s112), S6 (s235/236), S6 (s240/244) and 4EBP (s65), shows no effect on total BAD, S6 or 4EBP protein levels.
-
In Vivo——
-
SynonymsGNE955
-
PathwayJAK/STAT Signaling
-
TargetPim
-
RecptorPim
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1527523-39-2
-
Formula Weight415.501
-
Molecular FormulaC23H25N7O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=NC(C2=NC=C(C=NN3C4=CC=C(OC)C(N5CCC[C@H](N)C5)=C4)C3=C2)=CN=C1
-
Chemical Name(S)-1-(3-methoxy-6-(6-(6-methylpyrazin-2-yl)-1H-pyrazolo[4,3-c]pyridin-1-yl)pyridin-2-yl)piperidin-3-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang X, et al. J Med Chem. 2017 May 25;60(10):4458-4473.
molnova catalog
related products
-
K00135
K00135 is a selective inhibitor of Pim kinases and can be used in studies about gastric cancer and antileukemic therapeutics.
-
GSK2200150A
GSK2200150A, identified by high-throughput screening (HTS) campaign, is an anti-tuberculosis (TB) agent.
-
YLT-11
YLT-11 (PLK4 inhibitor YLT11) is a novel potent, selective, ATP-competitive PLK4 inhibitor with IC50 of 22 nM, Kd of 5.2 nM.
Cart
sales@molnova.com